Quest Partners LLC Boosts Stake in Axcelis Technologies, Inc. (NASDAQ:ACLS)

Quest Partners LLC grew its holdings in Axcelis Technologies, Inc. (NASDAQ:ACLSFree Report) by 51.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,975 shares of the semiconductor company’s stock after purchasing an additional 1,346 shares during the period. Quest Partners LLC’s holdings in Axcelis Technologies were worth $417,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also modified their holdings of the business. Royce & Associates LP lifted its position in Axcelis Technologies by 157.1% in the third quarter. Royce & Associates LP now owns 273,671 shares of the semiconductor company’s stock valued at $28,694,000 after buying an additional 167,235 shares during the last quarter. KBC Group NV raised its stake in shares of Axcelis Technologies by 30.3% in the 3rd quarter. KBC Group NV now owns 934 shares of the semiconductor company’s stock valued at $98,000 after acquiring an additional 217 shares during the period. Kovack Advisors Inc. lifted its holdings in shares of Axcelis Technologies by 11.9% in the 3rd quarter. Kovack Advisors Inc. now owns 3,280 shares of the semiconductor company’s stock worth $344,000 after acquiring an additional 350 shares during the last quarter. Oppenheimer & Co. Inc. purchased a new position in shares of Axcelis Technologies during the 3rd quarter worth approximately $493,000. Finally, Oppenheimer Asset Management Inc. boosted its position in shares of Axcelis Technologies by 70.5% during the 3rd quarter. Oppenheimer Asset Management Inc. now owns 3,436 shares of the semiconductor company’s stock worth $360,000 after purchasing an additional 1,421 shares during the period. 89.98% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the company. B. Riley decreased their price target on Axcelis Technologies from $190.00 to $165.00 and set a “buy” rating on the stock in a research note on Friday, August 2nd. Benchmark lowered Axcelis Technologies from a “buy” rating to a “hold” rating in a research note on Friday, November 8th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Axcelis Technologies in a research report on Friday, November 8th. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $167.33.

Check Out Our Latest Report on ACLS

Axcelis Technologies Stock Performance

Shares of Axcelis Technologies stock opened at $75.07 on Monday. Axcelis Technologies, Inc. has a one year low of $69.35 and a one year high of $158.61. The business has a 50-day simple moving average of $91.99 and a 200-day simple moving average of $111.20. The company has a debt-to-equity ratio of 0.04, a quick ratio of 3.29 and a current ratio of 4.45. The company has a market cap of $2.44 billion, a PE ratio of 11.11, a P/E/G ratio of 2.28 and a beta of 1.60.

About Axcelis Technologies

(Free Report)

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.

Read More

Want to see what other hedge funds are holding ACLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axcelis Technologies, Inc. (NASDAQ:ACLSFree Report).

Institutional Ownership by Quarter for Axcelis Technologies (NASDAQ:ACLS)

Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.